View Older Stories View More Recent Stories
-
H.C. Wainwright & Co., LLC Announces the Hiring of Ed Arce as Senior Biotechnology Analyst
-
Roth Capital Cuts Price Target on Golden Minerals Company (AUMN) After Updating Precious Metals Forecast
-
Roth Capital Upgrades New Gold (NGD) to Buy
-
EnteroMedics Inc. Announces Closing of $16.0 Million Public Offering of Common Stock and Warrants
-
PlacementTracker Publishes First Half 2015 PIPE Market League Tables
-
Roth Capital Starts 8point3 Energy Partners LP (CAFD) at Buy
-
Unique Fabricating, Inc. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option by Underwriters
-
Ballard Announces Close of U.S. Offering
-
EnteroMedics (ETRM) Prices 32M Common Stock, Warrants Unit Offering at 50c/Unit
-
EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants
-
Roth Capital Starts Biotie Therapies (BITI) at Buy
-
Pieris Pharmaceuticals Closes Public Offering of Common Stock
-
Roth Capital Remains Bullish on NeoGenomics (NEO) Ahead of 2Q15 Results
-
Roth Capital Says Recent Pullbacks on uniQure (QURE) Offers Attractive Entry points; Reiterates Buy
-
Roth Capital Positive on Biogen (BIIB), AGTC (ATGC) Collaboration; Reaffirms AGTC at 'Buy'
-
Iconix Investors: Lieff Cabraser Announces Class Action Litigation Against Iconix Brand Group, Inc. - ICON
-
Roth Capital Cuts Price Target on Franklin Covey (FC) Following EPS Miss
-
Roth Capital Starts Green Plains Partners LP (GPP) at Buy
-
Unique Fabricating (UFAB) Prices 2.35M Common Stock IPO at $9.50/Share
-
Roth Capital Reiterates Buy Following Palatin Technologies (PTN) 'Positive' AdCom for Sprout's Flibanserin
-
Unique Fabricating, Inc. Announces Pricing of Initial Public Offering
-
Ballard Power (BLDP) 8.13M Offering of Common Stock Prices at $1.60/Share
-
Ballard Announces Pricing of U.S. Offering
-
Acura Pharma (ACUR) Enters Securities Purchase Agreement for 9.8M Common at 78c/Share
-
Acura Pharmaceuticals to Raise Approximately $7.6 Million From Institutional Healthcare Investors
-
Roth Capital Cuts Price Target on IAMGOLD Corp. (IAG) Following Repercussions From May's Seismic Event
-
Roth Capital Remains Bullish on Power Solutions (PSIX) Following Courts Decision
-
Roth Capital raises Price Target on Trinity Biotech (TRIB) After Meeting with Management
-
Roth Capital Cuts Price Target on Calgon Carbon (CCC) Following SCOTUS Ruling
-
Pieris Pharma (PIRS) Prices 9.1M Common Stock Offering at $2.75/Share
-
Celgene/Juno Deal Bodes Well For Lion Biotechnologies (LBIO), Roth Capital Says
-
Pieris Pharmaceuticals Prices Public Offering of Common Stock
-
EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants
-
JinkoSolar (JKS) Falls as Analyst Doesn't See 'Take Private' Move
-
DSMB Decision on Celldex's (CLDX) RINTEGA was No Surprise; 'Focus Pick' Rating Reaffirmed
-
Sarepta Therapeutic (SRPT) NDA Submission Marks 'Significant De-risking Event', Roth Capital Says
-
Roth Capital Cuts Price Target on Micron Technology (MU) Following 3Q15 Results
-
Sapiens International (SPNS) PT to $12 at Roth Capital
-
Roth Capital Downgrades China Cord Blood (CO) to Neutral
-
Celator's (CPXX) CPX-351 Has Room to Grow in AML Space; Roth Capital Affirms at 'Buy'
-
Roth Positive on Keryx (KERX) Following Addition of Auryxia to Two Medicare Part D Formularies
-
Inphi Corp. (IPHI) PT Lifted to $30 at Roth Capital
-
Aethlon Medical Announces $6 Million Equity Investment
-
bluebird bio (BLUE) Prices 2.9M Common Share Offering at $170/Share
-
Roth Capital Starts Interactive Intelligence (ININ) at Buy
-
Roth Capital Starts Sphere 3D Corporation (ANY) at Buy
-
bluebird bio Announces Pricing of Public Offering of Common Stock
-
Ring Energy, Inc. Announces Completion of Public Common Stock Offering of 4,500,000 Shares
-
bluebird bio (BLUE) Announces $400M Common Stock Offering
-
bluebird bio Announces Proposed Public Offering of Common Stock

